Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma

behalf of the PRECISION ITALIA STUDY GROUP, on; Golfieri, Rita; Giampalma, Emanuela; Renzulli, Matteo; Cioni, Roberto; Bargellini, Irene; Bartolozzi, Carlo; Doriguzzi Breatta, Andrea; Gandini, G; Nani, Roberto; Gasparini, Daniele; Cucchetti, Alessandro; Bolondi, Luigi; Trevisani, Franco

doi:10.1038/bjc.2014.199

Public

Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma

Published in British Journal of Cancer • Jun 17, 2014

Authors:

on behalf of the PRECISION ITALIA STUDY GROUP

Rita Golfieri

Emanuela Giampalma

Abstract

BACKGROUND: Transcatheter arterial chemoembolisation (TACE) is the treatment of choice for intermediate stage hepatocellular carcinoma (HCC). Doxorubicin-loaded drug-eluting beads (DEB)-TACE is expected to improve the performance of conventional TACE (cTACE). The aim of this study was to compare DEB...

Subject

Medicine

Hepatocellular carcinoma

Internal medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!